PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-04-09

Date Title Company
09-Apr-2020 Emergent BioSolutions Appoints Nina DeLorenzo as Senior Vice President of Global Public Affairs Emergent BioSolutions
09-Apr-2020 INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today INOVIO
09-Apr-2020 REGENERON AND ZAI LAB ANNOUNCE REGIONAL STRATEGIC COLLABORATION FOR REGN1979 (CD20XCD3 BISPECIFIC ANTIBODY) Regeneron Pharmaceuticals
09-Apr-2020 PFIZER AND THE PFIZER FOUNDATION DONATE $40 MILLION IN CHARITABLE GRANTS, EXPAND PRODUCT ACCESS AND MOBILIZE COLLEAGUES TO COMBAT COVID-19 PANDEMIC Pfizer
09-Apr-2020 New $35 Co-Pay Now Available Through Lilly Insulin Value Program in Response to COVID-19 Crisis in U.S. Eli Lilly and Company
09-Apr-2020 Gilead Completes Acquisition of Forty Seven, Inc. Gilead Sciences
09-Apr-2020 Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery Gilead Sciences
09-Apr-2020 Moderna to Host Virtual Vaccines Day on April 14, 2020 Moderna
09-Apr-2020 Belgium and Canada provide funding boost for CEPI’s COVID-19 vaccine research CEPI
09-Apr-2020 Roche provides regulatory update on risdiplam for the treatment of spinal muscular atrophy (SMA) Roche
09-Apr-2020 Volunteer laboratory network launched to expand Covid-19 testing for key workers Covid-19 Volunteer Testing Network
09-Apr-2020 Excelra Releases COVID-19 Drug Repurposing Database to Support Global Drug Development Efforts Against Novel Coronavirus Excelra Knowledge Solutions Pvt Ltd
09-Apr-2020 Neptune Successfully Completes Submission to U.S. FDA for Registration of its Conover, NC Facility for Production of Hand Sanitizers Neptune Wellness Solutions Inc.
09-Apr-2020 Vigeo Therapeutics Doses First Patients in Expansion Phase of its 1b/2 Study Investigating VT1021 in Patients with CD36 Expressing Cancers Vigeo Therapeutics
09-Apr-2020 Vigeo Therapeutics Doses First Patients in Expansion Phase of its 1b/2 Study Investigating VT1021 in Patients with CD36 Expressing Cancers Vigeo Therapeutics
09-Apr-2020 MaxCyte Provides Business Update Related to COVID-19 Pandemic MaxCyte, Inc.
09-Apr-2020 Theravance Biopharma Responds to COVID-19 Pandemic by Advancing TD-0903 to Treat Hospitalized Patients with Acute Lung Injury Theravance Biopharma, Inc.
09-Apr-2020 Isosec and NHS Digital to fast-track availability of Virtual Smartcards RealWire
09-Apr-2020 M1 Kliniken AG: Corona pandemic: M1 Group extends clinic and practice closures until 24 April 2020 M1 Kliniken AG
09-Apr-2020 Global Veterinary Electrosurgery Market is Estimated to be Worth USD 54.42 million in 2019 and is Projected to Reach USD 104.71 million by 2027, at A CAGR of 7.8% From 2019 to 2026: Proficient Market Wired Release